Wanbury Ltd's earnings have grown by 0%, whereas share price has appreciated 8.2% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.
Wanbury Ltd share price has appreciated 12.4% annually (CAGR) over the past ten years.
Data is not available for this company.
Wanbury was incorporated in 1990 as a private limited company under the name of Pearl Distributors Private Limited. The name of the company was changed to 'Pearl Organics Private Limited on January 17, 1991 and the company was converted into a public limited company on August 6, 1991.
Wanbury is the fastest growing pharma company amongst top 100 companies in India as per ORG-IMS has strong presence in domestic branded formulations. Wanburyâ€™s major thrust area also lies in Active
Wanbury is the fastest growing pharma company amongst top 100 companies in India as per ORG-IMS has strong presence in domestic branded formulations. Wanburyâ€™s major thrust area also lies in Active Pharmaceutical Ingredient (API) and Contract Research and Manufacturing Services (CRAMS). It has a presence in Spain through its branded formulation business - Cantabria Pharma S. L acquired in 2006.
The company is having 3 API manufacturing facilities including 2 US FDA approved multi-product API facilities for regulated markets.
Product range of the company includes:
2008Wanbury opened an office in Zurich, Switzerland for its CRAMS business. Wanbury incorporated Wanbury Global FZE in Middle East for expanding its global business.Wanbury achieved consolidated turnover of Rs. 630 crore for 18 months period ended 30th September 2008. Rabiplus was awarded â€˜Best Brand Launchâ€™ by ORG-IMS as it did sales of Rs.13.8 crores in launch Year. Wanbury is the fastest growing company among top 100 companies in India as per ORG-IMS.
2007Doctorâ€™s Organics Chemicals merged with Wanbury. Wanbury entered into a strategic association with Bravo Healthcare Wanbury incorporated Ningxia Wanbury Fine Chemicals Co to source raw materials from China. Wanbury approved as preferred Vendor by Pfizer (US) for Contract Research and Manufacturing Services (CRAMS). Cpink was awarded â€˜Best Brand Launchâ€™ by ORG-IMS as it did sales of Rs. 11 crores in launch year. Wanbury is the fastest growing company among top 100 companies in India as per ORG-IMS.
2006Wanbury achieved 100 crore turnover. Pharmaceutical Products of India (PPIL) merged with Wanbury pursuant to BIFR order. Wanbury acquired Cantabria Pharma S.L. with presence in ethical branded formulations in the Spanish market. Wanbury crossed 1000 employees mark. Wanbury became the worldâ€™s largest producer of Metformin with production of 4500 MT.
2005Wanbury acquired Doctorâ€™s Organics and Chemicals, having a US FDA approved facility for manufacturing multi-product APIâ€™s.
2004Wander merged with Pearl Organics Limited and Pearl Organics renamed as Wanbury Wanbury set up its R & D center in Navi Mumbai for API. Wanbury started using SAP as a business transaction system.
2002Pearl Organics got US FDA approval for Patalganga plant.
1996Pearl Organics entered into a strategic alliance with Wyckoff Chemicals (US) to market its API in US.
1995Pearl Organics acquired plant of Brij Chemicals Pvt at Patalganga (Maharashtra).
1992Pearl Organics established its first plant in Tarapur for manufacturing APIâ€™s.
1991Pearl Distributors Pvt went public and was renamed as Pearl Organics.
1990Incorporated as Pearl Distributors Pvt